Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Hippocampus: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
Knowledge base pages for this entity
graph TD
Hippocampus["Hippocampus"]
Memory["Memory Formation"]
Cortisol["Cortisol"]
Alzheimers["Alzheimer's Disease"]
Amyloid["Amyloid Pathology"]
Microglia["Microglial Activation"]
Neuroinflammation["Neuroinflammation"]
Complement["Complement System"]
C1QA["C1QA"]
SPP1["SPP1"]
GRN["Granulin"]
CTSB["Cathepsin B"]
NF_kB["NF-kappaB Signaling"]
HCN1["HCN1 Channels"]
Phagocytosis["Phagocytosis"]
Neurotoxicity["Neurotoxicity"]
miR_137["miR-137-3p"]
Hippocampus -->|"enables"| Memory
Cortisol -->|"modulates"| Hippocampus
Alzheimers -->|"affects"| Hippocampus
Amyloid -->|"accumulates in"| Hippocampus
Amyloid -->|"activates"| Microglia
Microglia -->|"triggers"| Neuroinflammation
Neuroinflammation -->|"activates"| Complement
Complement -->|"expresses"| C1QA
C1QA -->|"promotes"| Phagocytosis
SPP1 -->|"regulates"| Microglia
GRN -->|"modulates"| Neuroinflammation
CTSB -->|"degrades"| Amyloid
Neuroinflammation -->|"activates"| NF_kB
NF_kB -->|"promotes"| Neurotoxicity
HCN1 -->|"regulates"| Hippocampus
miR_137 -->|"expressed in"| Hippocampus
Neurotoxicity -->|"damages"| Hippocampus
style Hippocampus fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
style Memory fill:#1b5e20,stroke:#4caf50,stroke-width:2px
style CTSB fill:#1b5e20,stroke:#4caf50,stroke-width:2px
style GRN fill:#1b5e20,stroke:#4caf50,stroke-width:2px
style Phagocytosis fill:#1b5e20,stroke:#4caf50,stroke-width:2px
style Alzheimers fill:#7d4200,stroke:#ff9800,stroke-width:2px
style Amyloid fill:#ef5350,stroke:#f44336,stroke-width:2px
style Neuroinflammation fill:#ef5350,stroke:#f44336,stroke-width:2px
style Neurotoxicity fill:#ef5350,stroke:#f44336,stroke-width:2px
style HCN1 fill:#4a1a6b,stroke:#ba68c8,stroke-width:2px
style SPP1 fill:#4a1a6b,stroke:#ba68c8,stroke-width:2px
style miR_137 fill:#4a1a6b,stroke:#ba68c8,stroke-width:2px
style NF_kB fill:#4a1a6b,stroke:#ba68c8,stroke-width:2px| Target | Relation | Type | Str |
|---|---|---|---|
| Post-Stroke Depression | correlates_with | disease | 0.85 |
| Memory | activates | entity | 0.70 |
| NEURONS | activates | concept | 0.50 |
| TEMPORAL LOBE | associated_with | concept | 0.50 |
| ALZHEIMER'S | inhibits | concept | 0.50 |
| White Matter | inhibits | process | 0.50 |
| PREFRONTAL CORTEX | associated_with | concept | 0.50 |
| ALZHEIMER'S | activates | concept | 0.50 |
| HYPOTHALAMUS | associated_with | concept | 0.50 |
| GENE EXPRESSION | expressed_in | concept | 0.50 |
| ENTORHINAL CORTEX | expressed_in | concept | 0.50 |
| AMYLOID-β | inhibits | concept | 0.50 |
| DOPAMINE | activates | concept | 0.50 |
| SEROTONIN | activates | concept | 0.50 |
| DOPAMINE | associated_with | concept | 0.50 |
| SEROTONIN | associated_with | concept | 0.50 |
| GLUTAMATE | activates | concept | 0.50 |
| EXCITOTOXICITY | activates | concept | 0.50 |
| DENDRITIC SPINE | inhibits | concept | 0.50 |
| Cognitive Impairment | inhibits | phenotype | 0.50 |
| ALZHEIMER'S | expressed_in | concept | 0.50 |
| NUCLEUS | expressed_in | concept | 0.50 |
| Substantia Nigra | associated_with | entity | 0.50 |
| GENE EXPRESSION | activates | concept | 0.50 |
| DENDRITIC SPINE | activates | concept | 0.50 |
| NEURONS | associated_with | concept | 0.50 |
| cGAS-STING pathway | activates | pathway | 0.50 |
| FRONTAL | activates | concept | 0.50 |
| AMYGDALA | activates | concept | 0.50 |
| ALZHEIMER'S | interacts_with | concept | 0.50 |
| GENE EXPRESSION | interacts_with | concept | 0.50 |
| GENE EXPRESSION | regulates | concept | 0.50 |
| ENDOTHELIAL | activates | concept | 0.50 |
| ENDOTHELIAL CELLS | activates | concept | 0.50 |
| Proteins | expressed_in | protein | 0.50 |
| PREFRONTAL CORTEX | interacts_with | concept | 0.50 |
| White Matter | associated_with | process | 0.50 |
| CEREBRAL CORTEX | associated_with | concept | 0.50 |
| Cognitive Impairment | activates | phenotype | 0.50 |
| GLUTAMATE | inhibits | concept | 0.50 |
| Sphingolipid | associated_with | pathway | 0.50 |
| SGMS1 | inhibits | concept | 0.50 |
| CEREBELLUM | expressed_in | concept | 0.50 |
| SGMS1 | expressed_in | concept | 0.50 |
| Proteins | activates | protein | 0.50 |
| CEREBRAL CORTEX | activates | concept | 0.50 |
| ALZHEIMER'S | regulates | concept | 0.50 |
| AUTOPHAGOSOME | inhibits | concept | 0.50 |
| CEREBRAL CORTEX | inhibits | concept | 0.50 |
| STRIATUM | interacts_with | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Neurodegeneration-Related Gene Expression | expressed_in | process | 0.90 |
| PVB | expressed_in | gene | 0.90 |
| Cortisol | modulates | compound | 0.85 |
| MCH | expressed_in | protein | 0.85 |
| LARS2 | expressed_in | gene | 0.85 |
| Neuronal Cholesterol Accumulation | expressed_in | phenotype | 0.85 |
| Gabaergic Interneurons | expressed_in | cell_type | 0.85 |
| Cadmium | causes | compound | 0.85 |
| 1-Bromopropane | targets | compound | 0.85 |
| TDP-43 Pathology | expressed_in | phenotype | 0.82 |
| Haloperidol | causes | drug | 0.80 |
| miR-137-3p | expressed_in | biomarker | 0.80 |
| 5-Hydroxymethylcytosine | expressed_in | compound | 0.80 |
| Long-Term Potentiation | expressed_in | process | 0.80 |
| CTF-η | expressed_in | protein | 0.80 |
| SLC17A7 | expressed_in | gene | 0.60 |
| HCN1 | expressed_in | gene | 0.55 |
| EPILEPSY | expressed_in | gene | 0.55 |
| PHAGOCYTOSIS | expressed_in | gene | 0.55 |
| COMPLEMENT | expressed_in | gene | 0.55 |
| AMYLOID | expressed_in | gene | 0.55 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 0.55 |
| SPP1 | expressed_in | gene | 0.55 |
| MICROGLIA | expressed_in | gene | 0.55 |
| ALZHEIMER | expressed_in | gene | 0.55 |
| NEURODEGENERATIVE DISEASES | expressed_in | gene | 0.55 |
| CTSB | expressed_in | gene | 0.55 |
| GRN | expressed_in | gene | 0.55 |
| C1QA | expressed_in | gene | 0.55 |
| DEMENTIA | expressed_in | gene | 0.55 |
| NF-ΚB | expressed_in | gene | 0.55 |
| C1Q | expressed_in | gene | 0.55 |
| ANXIETY | expressed_in | gene | 0.55 |
| GENES | expressed_in | gene | 0.55 |
| NEUROTOXICITY | expressed_in | gene | 0.55 |
| NEUROINFLAMMATION | expressed_in | gene | 0.55 |
| NEURODEGENERATIVE DISORDERS | expressed_in | gene | 0.55 |
| BLOOD-BRAIN BARRIER DYSFUNCTION | expressed_in | gene | 0.55 |
| APOE4 | expressed_in | gene | 0.55 |
| TAU PATHOLOGY | expressed_in | gene | 0.55 |
| PERICYTE | expressed_in | gene | 0.55 |
| TAU | expressed_in | gene | 0.55 |
| HUNTINGTON | expressed_in | gene | 0.55 |
| SYNAPSE | expressed_in | gene | 0.55 |
| INFLAMMATION | expressed_in | gene | 0.55 |
| TREM2 | expressed_in | gene | 0.55 |
| ERBB4 | expressed_in | gene | 0.55 |
| NRG1 | expressed_in | gene | 0.55 |
| SYN3 | expressed_in | gene | 0.55 |
| DEPRESSION | expressed_in | gene | 0.55 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||